Stay updated on Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial page.

Latest updates to the Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference3%

- Check28 days agoChange DetectedPage now shows version upgrade to v3.1.0 and adds two new contact-like numbers (82-10-9933-3483 and 82-2-3410-6763), replacing the old version tag v3.0.2.SummaryDifference0.1%

- Check42 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2 to indicate a new release. The 'Back to Top' link was removed as a minor navigational change.SummaryDifference0.2%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated to include specific facility information and a new publication related to pembrolizumab therapy for lung adenocarcinoma, while some previous location and resource details have been removed.SummaryDifference7%

- Check71 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial page.